SkinBioTherapeutics Plc

(LSE) SBTX

Current Price£0.12

Market Cap£30.45M

Since IPO (2017)-13%

5 Year-82%

1 Year-29%

1 Month+21%

SkinBioTherapeutics Plc Financials at a Glance

Market Cap

£30.45M

Revenue (TTM)

£7.91M

Net Income (TTM)

-£3.03M

EPS (TTM)

-£0.00

P/E Ratio

-65.28

Dividend

£0.00

Beta (Volatility)

0.03 (Low)

Dividend

£0.00

Beta (Volatility)

0.03 (Low)

Price

£0.12

Volume

1,738,536

Open

£0.12

Price

£0.12

Volume

1,738,536

Open

£0.12

Previous Close

£0.12

Daily Range

£0.12 - £0.13

52-Week Range

£0.05 - £0.23

Estimated Earnings Date

Dec 2, 2026

Dividend

£0.00

Beta (Volatility)

0.03 (Low)

Price

£0.12

Volume

1,738,536

Open

£0.12

Previous Close

£0.12

Daily Range

£0.12 - £0.13

52-Week Range

£0.05 - £0.23

Estimated Earnings Date

Dec 2, 2026

SBTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SkinBioTherapeutics Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stuart John Ashman

Website

www.skinbiotherapeutics.com

Headquarters

Newcastle upon Tyne, NE4 5TF, GB

SBTX Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-21%

Net Income Margin

-9%

Return on Equity

-7%

Return on Capital

-12%

Return on Assets

-5%

Earnings Yield

-1.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£30.45M

Shares Outstanding

259.17M

Volume

1.74M

Avg. Volume

599.52K

Financials (TTM)

Gross Profit

£2.71M

Operating Income

-£826.79K

EBITDA

-£196.54K

Operating Cash Flow

-£1.30M

Capital Expenditure

-£6.30K

Free Cash Flow

-£1.30M

Cash & ST Invst.

£4.78M

Total Debt

£993.47K

SkinBioTherapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

£2.17M

+1932.3%

Gross Profit

£1.13M

+1550.3%

Gross Margin

51.98%

N/A

Market Cap

£30.45M

N/A

Market Cap/Employee

£2.03M

N/A

Employees

N/A

Net Income

-£794.26K

+40.5%

EBITDA

-£757.08K

+44.4%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

£3.12M

+10.0%

Total Debt

£939.17K

+867.7%

Accounts Receivable

£757.91K

+360.6%

Inventory

£925.20K

+1870.7%

Long Term Debt

£842.67K

+1311.8%

Short Term Debt

£96.50K

+29.1%

Return on Assets

-4.75%

N/A

Return on Invested Capital

-12.42%

N/A

Free Cash Flow

-£1.55M

-12.4%

Operating Cash Flow

-£1.53M

-12.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CREO.LCreo Medical Limited

CREO.LCreo Medical Limited£0.14+0.00%

KOO.LKooth plc

KOO.LKooth plc£1.62-0.62%

HVO.LhVIVO plc

HVO.LhVIVO plc£0.08+0.00%

POLB.LPoolbeg Pharma PLC

POLB.LPoolbeg Pharma PLC£0.08-2.92%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc£7.78+4.36%

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc£0.22-4.35%

IMM.LImmuPharma plc

IMM.LImmuPharma plc£0.05-1.96%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$191.82-0.05%

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.42-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$17.42-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.97+0.00%

Questions About SBTX

What is the current price of SkinBioTherapeutics Plc?

SkinBioTherapeutics Plc is trading at £0.12 per share.

What is the 52-week range for SkinBioTherapeutics Plc?

Over the past 52 weeks, SkinBioTherapeutics Plc has traded between £0.05 and £0.23.

How much debt does SkinBioTherapeutics Plc have?

As of the most recent reporting period, SkinBioTherapeutics Plc reported total debt of £993.47K.

How much cash does SkinBioTherapeutics Plc have on hand?

SkinBioTherapeutics Plc reported £4.78M in cash and cash equivalents in its most recent financial results.

What is SkinBioTherapeutics Plc’s dividend yield?

SkinBioTherapeutics Plc does not currently have a dividend yield.

SkinBioTherapeutics Plc

SkinBioTherapeutics Plc Financials at a Glance

SBTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About SkinBioTherapeutics Plc

SBTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

SkinBioTherapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SBTX

What is the current price of SkinBioTherapeutics Plc?

What is the 52-week range for SkinBioTherapeutics Plc?

How much debt does SkinBioTherapeutics Plc have?

How much cash does SkinBioTherapeutics Plc have on hand?

What is SkinBioTherapeutics Plc’s dividend yield?

Premium Investing Services